Medinice (77E) Stock Overview

A medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. More details

77E fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Revenue is forecast to grow 178.06% per year

Risk Analysis

Makes less than USD$1m in revenue (PLN0)

Shareholders have been diluted in the past year

Volatile share price over the past 3 months compared to the German market

77E Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW480,107 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

480,107 investors already sharing narratives

View all narratives

Medinice S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medinice
Historical stock prices
Current Share Price	zł16.24
52 Week High	zł21.55
52 Week Low	zł9.61
Beta	1.12
1 Month Change	-1.58%
3 Month Change	-4.69%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	68.99%

Recent updates

Shareholder Returns

	77E	DE Medical Equipment	DE Market
7D	-1.7%	-0.1%	0.1%
1Y	n/a	-26.5%	-0.5%

Return vs Industry: Insufficient data to determine how 77E performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 77E performed against the German Market.

Price Volatility

Is 77E's price volatile compared to industry and market?
77E volatility
77E Average Weekly Movement	11.1%
Medical Equipment Industry Average Movement	6.1%
Market Average Movement	5.3%
10% most volatile stocks in DE Market	12.7%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: 77E's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 77E's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2012	10	Sanjeev Choudhary	www.medinice.pl

Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium; and AtriClamp, a clip designed to close the left atrial appendage to minimize the risk of stroke in patients with atrial fibrillation. It also provides MiniMax, an ablation-mapping catheter used for detecting intracardiac electrophysiological signals, creating a 3D map of the heart, and performing intracardiac irrigated RF ablation to treat arrhythmias caused by abnormalities in the heart’s conduction system; and EP Bioptom, an electrode for endomyocardial biopsy using 3D mapping enabling simultaneous biopsy and creation of a three-dimensional heart map.

Medinice S.A. Fundamentals Summary

How do Medinice's earnings and revenue compare to its market cap?
77E fundamental statistics
Market cap	€156.97m
Earnings (TTM)	-€1.58m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-99.3x

P/E Ratio

Is 77E overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
77E income statement (TTM)
Revenue	zł0
Cost of Revenue	zł205.00k
Gross Profit	-zł205.00k
Other Expenses	zł6.64m
Earnings	-zł6.84m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Sep 11, 2026

Earnings per share (EPS)	-0.74
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0%

How did 77E perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/23 02:53
End of Day Share Price	2026/07/23 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medinice S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Dawid Górzynski	PKO BP Securities

Medinice S.A.DB:77E Stock Report